Release and velocity of micronized dexamethasone implants with an intravitreal drug delivery system: Kinematic analysis with a high-speed camera

Retina

Volumn 32, Issue 10, 2012, Pages 2133-2140

  Meyer, Carsten H ^a   Klein, Adrian ^a   Alten, Florian ^a   Liu, Zengping ^a   Stanzel, Boris V ^a   Helb, Hans M ^a   Brinkmann, Christian K ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Drug delivery; Highspeed camera; Kinematic analysis; Release; Velocity

Indexed keywords

DEXAMETHASONE; WATER;

ARTICLE; CAMERA; DRUG DELIVERY SYSTEM; DRUG IMPLANT; DRUG RELEASE; KINEMATICS; RETINA; VELOCITY; VITREOUS BODY;

ABSORBABLE IMPLANTS; BIOMECHANICS; DEXAMETHASONE; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; GLUCOCORTICOIDS; HUMANS; PHOTOGRAPHY; VITREOUS BODY;

EID: 84871303992     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31825699e5     Document Type: Article

References (18)

1. Haller JA, Dugel P, Weinberg DV, et al. Evaluation of the safety and performance of an applicator for a novel intravitreal dexamethasone drug delivery system for the treatment of macular edema. Retina 2009;29:46-51.
2. Kuppermann BD, Chou C, Weinberg DV, et al; Dexamethasone DDS Phase II Study Group. Intravitreous dexamethasone effects on different patterns of diabetic macular edema. Arch Ophthalmol 2010;128:642-643.
3. Chang-Lin JE, Attar M, Acheampong AA, et al. Pharmacokinetics and pharmacodynamics of the sustained-release dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci 2011;52:80-86.
4. Haller JA, Kuppermann BD, Blumenkranz MS, et al; Dexamethasone DDS Phase II Study Group. Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. Arch Ophthalmol 2010; 128:289-296.
5. Haller JA, Bandello F, Belfort R Jr, et al; OZURDEX GENEVA Study Group. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 2010;117: 1134-1146.
6. Meyer CH, Krohne TU, Issa PC, Holz FG. Routes for drug delivery to the eye and retina: intravitreal injections and vitrectomy. In: Nguyen QD, Rodrigues EB, Farah ME, Mieler WF, eds. Retinal Pharmacotherapy. Saunders Elsevier; 2010:67-73:chap 10.
7. Duma SM, Ng TP, Kennedy EA, et al. Determination of significant parameters for eye injury risk from projectiles. J Trauma 2005;59:960-964.
8. Kratz A, Levy J, Cheles D, et al. Airsoft gun-related ocular injuries: novel findings, ballistics investigation, and histopathologic study. Am J Ophthalmol 2010;149:37-44.
9. Hubschman JP, Bourges JL, Tsui I, et al. Effect of cutting phases on flow rate in 20-, 23-, and 25-gauge vitreous cutters. Retina 2009;29:1289-1293.
10. Sharif-Kashani P, Hubschman JP, Sassoon D, Pirouz Kavehpour H. Rheology of the vitreous gel: effects of macromolecule organization on the viscoelastic properties. J Biomech 2011;44:419-423.
11. Walton KA, Harkrider CJ, Cox TA, Toth CA. Age-related changes in vitreous mobility as measured by video B scan ultrasound. Exp Eye Res 2002;74:173-180.
12. Costa Ede P, Rodrigues EB, Farah ME, et al. Novel vitreous modulators for pharmacologic vitreolysis in the treatment of diabetic retinopathy. Curr Pharm Biotechnol 2011;12: 410-422.
13. Boyer DS, Faber D, Gupta S, et al; Ozurdex CHAMPLAIN Study Group. Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients. Retina 2011;31:915-923.
14. Arevalo JF, Mendoza AJ, Velez-Vazquez W, et al. Full-thickness macular hole after LASIK for the correction of myopia. Ophthalmology 2005;112:1207-1212.
15. Hagemann LF, Costa RA, Ferreira HM, Farah ME. Optical coherence tomography of a traumatic Neodymium: YAG laser-induced macular hole. Ophthalmic Surg Lasers Imaging 2003;34:57-59.
16. Bertelmann T, Kicová N, Messerschmidt-Roth A, et al. The vitreomacular interface in retinal vein occlusion. Acta Ophthalmol 2011;89:327-331.
17. Bakri SJ, Omar AF. Evolution of Vitreomacular Traction Following the Use of the Dexamethasone Intravitreal Implant (Ozurdex) in the Treatment of Macular Edema Secondary to Central Retinal Vein Occlusion. http://www.ncbi.nlm.nih.gov/- pubmed/22537269 J Ocul Pharmacol Ther 2012 online Apr 26.
18. Schmitz K, Maier M, Clemens CR, et al. Reliability and safety of intravitreal Ozurdex injections: The ZERO-study. Ophthalmologe 2012.